Integra Lifesciences Holdings (IART) Restructuring Costs (2011 - 2012)
Integra Lifesciences Holdings (IART) posted Restructuring Costs of $49.3 million for Q2 2012, up 5.56% sequentially from $46.7 million in Q1 2012, and down 10.75% YoY from $55.2 million in Q3 2011.
Integra Lifesciences Holdings (IART) Restructuring Costs (2011 - 2012) Analysis & Trends
Integra Lifesciences Holdings has reported Restructuring Costs for 2 years, with the latest figure at $49.3 million in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.33 Bn | 1.06 Bn | 219.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 49.27 Mn |
| Mar 31, 2012 | 46.68 Mn |
| Jun 30, 2011 | 55.20 Mn |
| Mar 31, 2011 | 39.39 Mn |